**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 345-78-8 |(1S,2S)-(+)-Pseudoephedrine hydrochlor| 99+ | 206-462-1 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 22 36/37/38
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful if swallowed. Irritating to eyes, respiratory system and
skin.Light sensitive.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May be harmful if absorbed through the
skin.
Ingestion:
Harmful if swallowed. May cause irritation of the digestive tract.
The toxicological properties of this substance have not been fully
investigated. May cause central nervous system effects and/or
neurological effects.
Inhalation:
Causes respiratory tract irritation. The toxicological properties of
this substance have not been fully investigated. May be harmful if
inhaled.
Chronic:
Prolonged or repeated exposure can cause psychic abnormalities such
as anxiety, depression and excitability. Prolonged exposure may
cause mental changes such as hallucinations, depression, psychosis,
and possibly coma. Repeated or prolonged exposure may cause CNS
stimulation.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid immediately. Flush skin with plenty of water for at
least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Do not induce vomiting. If victim is conscious and alert, give 2-4
cupfuls of milk or water. Never give anything by mouth to an
unconscious person. Get medical aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh
air immediately. If not breathing, give artificial respiration. If
breathing is difficult, give oxygen.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Clean up spills immediately, observing precautions in the
Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Use only in a well-ventilated area.
Minimize dust generation and accumulation. Avoid contact with eyes,
skin, and clothing. Keep container tightly closed. Avoid ingestion
and inhalation. Store protected from light.
Storage:
Keep refrigerated. (Store below 4C/39F.) Store protected from
moisture. Store protected from light.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 345-78-8:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Powder
Color: white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 183-186 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C10H15NOClH
Molecular Weight: 201.7
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures. Sensitive to light.
Hygroscopic: absorbs moisture or water from the air.
Conditions to Avoid:
Light, dust generation, exposure to moist air or water.
Incompatibilities with Other Materials:
Oxidizing agents, acids, acetic anhydride, acid chlorides.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Will not occur.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 345-78-8: UL5950000
LD50/LC50:
CAS# 345-78-8: Oral, mouse: LD50 = 371 mg/kg.
Carcinogenicity:
(1S,2S)-(+)-Pseudoephedrine hydrochloride -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
IMO
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
RID/ADR
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing group:
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 22 Harmful if swallowed.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 345-78-8: No information available.
Canada
CAS# 345-78-8 is listed on Canada's DSL List.
CAS# 345-78-8 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 345-78-8 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 7/31/1997 Revision #5 Date: 2/10/2005
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
P-Isopropylcalix[8]arene
| |
|
P-Isopropyldihomooxacalix[4]arene
| |
|
Maltitol, 95% (tlc)
| 585-88-6 |
|
Methanesulfonamide, 98% (hplc)
| 3144-09-0 |
|
3-(4-Methoxyphenyl)pyrazole, 99+%
| 27069-17-6 |
|
4'-Methylacetanilide
| 103-89-9 |
|
2-Methyl-1-Propanol, P.A.
| 78-83-1 |
|
5-Methyl-2-Pyrazinecarboxylic Acid, 99%
| 5521-55-1 |
|
2-(2,3,4,5,6-Pentafluorophenoxy)ethanol, 93% (gc)
| |
|
2-Amino-4-Hydroxy-6-Methylpyrimidine
| 3977-29-5 |
|
2,3,4,5,6-Pentafluorophenylacetonitrile
| 653-30-5 |
|
(1R,2R)-(-)-Pseudoephedrine
| 321-97-1 |
|
(s)-(-)-Amino-2-(1'-methoxy-1'-ethylpropyl )pyrrolidine
| 118535-62-9 |
|
(1S,2S)-(+)-Pseudoephedrine hydrochloride
| 345-78-8 |
|
Tetrafluorohydroquinone, 98%
| 771-63-1 |
|
2,2,3,3-Tetrafluoro-1-propanol
| 76-37-9 |
|
Alpha, alpha, alpha', alpha'-tetramethylhe ptanedioic acid
| 2941-45-9 |
|
3-(2-Thienyl) Pyrazole, 99+%
| 19933-24-5 |
|
3-(4-Tolyl)pyrazole, 99+%
| 59843-75-3 |
|
Tributyl(vinyl)tin
| 7486-35-3 |
|
Zeolite Without Alumina Acid Sites, Ratio SiO2/Al2O3 = 1000
| 1318-02-1 |
|
(1s,2s) - (+)- Pseudoephedrine
| 90-82-4 |
|
Tributylethynylstannane
| 994-89-8 |
|
(2S,3S)-2,3-Epoxybutan
| 21490-63-1 |
|
DL-2-Phenyl-3-Butyn-2-Ol, 98+%
| 127-66-2 |
|
2,6-Dimethoxyacetophenone, 99+%
| 2040-04-2 |
|
1-Bromo-N,N,2-Trimethylpropenylamine
| 73630-93-0 |
|
(R,R)-bis(2,2'-phenylthiomethyl)dihydropyran
| 0-00-0 |
|
(s,s)-bis(2,2'-phenylthiomethyl)dihydropyran
| |
|
2',4'-Dichloroacetophenone, 98.5% (GC)
| 2234-16-4 |
|
Phenoxy-2-Propanone, 97%
| 621-87-4 |
|
D,L-6-Hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid
| 134388-87-7 |
|
erythro-D,L-beta-Methylphenylalanine hydrochloride
| |
|
N-BOC-erythro-D,L,beta-Methylphenylalanine
| |
|
N-BOC-erythro-D-beta-Methylphenylalanine
| |
|
N-BOC-erythro-L-beta-Methylphenylalanine
| |
|
D,L-2-Aminotetralin-2-Carboxylic Acid
| 6331-63-1 |
|
N-Boc-D,L-2-Aminotetralin-2-Carboxylic Acid
| |
|
2-Aminoindan-2-carboxylic acid hydrochlori de
| |
|
N-FMOC-2-Aminoindan-2-carboxylic acid
| 135944-07-9 |
|
4-AMINOINDANE
| 32202-61-2 |
|
Aminomethylcyclopropane, 97%
| 2516-47-4 |
|
2-Chloro-5-Fluorophenol, 98%
| 3827-49-4 |
|
L-7-Hydroxy-1,2,3,4-tetrahydroisoquinoline -3-carboxylic acid
| 128502-56-7 |
|
Ether, stabilized, c.p.
| 60-29-7 |
|
Ether, reagent ACS, anhydrous, stabilized
| 60-29-7 |
|
Benzyltriethylammonium borohydride, 96%
| 85874-45-9 |
|
2-Methyl-1,3-dioxolane
| 497-26-7 |
|
4-Methyl-1,3-dioxolane
| 1072-47-5 |
|
2,6-Di-tert. butyl-4-methylphenol
| 128-37-0 |
|
|